# Evaluation of the Ability of CT-based Finite Element Analysis (CTFEA) to Predict Fractures in Patients With Metastases: a Randomized Controlled Study.

> **NCT03453905** · NA · UNKNOWN · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 162 (estimated)

## Conditions studied

- Bone Neoplasm of Hip (Diagnosis)
- Orthopedic Disorder
- Bone Metastases
- Proximal Femoral Metaphyseal Abnormality

## Interventions

- **DIAGNOSTIC_TEST:** CTFEA
- **OTHER:** Conventional decision algorithm

## Key facts

- **NCT ID:** NCT03453905
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-03-01
- **Primary completion:** 2022-03-01
- **Final completion:** 2022-03-01
- **Target enrollment:** 162 (ESTIMATED)
- **Last updated:** 2018-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03453905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03453905, "Evaluation of the Ability of CT-based Finite Element Analysis (CTFEA) to Predict Fractures in Patients With Metastases: a Randomized Controlled Study.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03453905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*